✦ LIBER ✦
416 XGFR* is a Novel Tri-functional Anti-EGFR/IGF-1R Antibody Blocking Key Tumor Signaling Pathways and Activating Host Immune Functions for Targeted Treatment of Pancreatic Cancer
✍ Scribed by Friess, T.; Schanzer, J.M.; Ruge, E.; Dimoudis, N.; Hoves, S.; Ooi, C.H.; Otz, T.; Bacac, M.; Weisser, M.; Wartha, K.
- Book ID
- 121990837
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 55 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.